Browse news articles across local and national media outlets.
- Photos: “The Voice”’s Andrew Marshall Shines at Mass General Cancer Center’s CenterStage Event
05/25/2022: Boston Magazine features event benefitting the Mass General Cancer Center - Recap: Advances in Systemic Therapy of Differentiated Thyroid Cancer Across Lines of Therapy
05/24/2022: Cancer Network quotes MGH physician Lori Wirth - Cancer experts hail a molecular ‘black box’ that records how cells fly into tumor territory
05/18/2022: STAT News quotes MGH researcher Kamila Naxerova - Will you get breast cancer in five years? Austin-based Clairity working on predictive tech
05/16/2022: Austin American-Statesman quotes Mass General Cancer Center researcher Connie Lehman - Recap: Treatment Advances in Chronic GVHD
05/15/2022: Cancer Network quotes MGH physician Yi-Bin Chen - Early Vs Delayed Surgery Associated With Improved Survival in Stage II/III Esophageal Cancer
05/13/2022: Cancer Network coverage of study led by MGH surgeon Chi-Fu Jeffrey Yang - Using targeted therapies for NTRK-fusion-positive thyroid cancer
05/12/2022: Targeted Oncology highlights Mass General Cancer Center physician Lori Wirth - Protecting the Bravest: Study offers new hope to firefighters exposed to toxic chemicals on the job
05/10/2022: WHDH quotes Mass General Cancer Center physician Lecia Sequist - New research could bring life-saving benefits of CAR T therapy to AML patients
05/10/2022: Drug Target Review coverage of study by MGH investigator Mark Leick - Study Supports Colonoscopies for Women Under 50
05/10/2022: HealthDay coverage of study by MGH investigator Andrew Chan - Starting colon, rectal cancer screening earlier reduces risk in women, study finds
05/06/2022: UPI coverage of study led by Mass General Cancer Center investigator Andy Chan - Ellie Fund offers a helping hand to those fighting breast cancer
05/04/2022: Boston Globe features Mass General Cancer Center’s Amy Comander and Bev Moy - Cancer is stalking Asian American men. Science isn’t doing enough
04/29/2022: Men’s Health showcases commentary from MGH oncologist Richard Lee - Gender bias common in online reviews of physicians
04/29/2022: Renal & Urology News quotes MGH physician Sophia Kamran - Liso-Cel Yields Long-Lasting Responses in Relapsed/Refractory Large B-Cell Lymphoma
04/24/2022: Cancer Network quotes MGH physician Jeremy Abramson - Age, skin cancer risks for ICI-induced bullous pemphigoid
04/21/2022: Medscape News quotes MGH physician Ryan Sullivan - OncView™ Podcast: EGFR Exon 20 Insertion as a Therapeutic Target in NSCLC
04/19/2022: Cancer Network interview with MGH oncologist Sofia Piotrowska - Newton's Dr. Weinstein set for 30th Boston Marathon in support of Mass General cancer patients
04/16/2022: Wicked Local.com coverage of MGH physician Howard Weinstein - ‘This is our fight against cancer’: Researchers find HIV drug promising for cancer treatment
04/15/2022: Harvard Crimson coverage of study co-led by MGH investigator David Ting - Oncologist to run his 30th Boston Marathon with vision of ‘curing all children with cancer’
04/15/2022: Healio profile of MGH physician Howard Weinstein - Cervical cancer: Single-dose HPV vaccine 'highly effective'
04/14/2022: Medical News Today coverage of study led by MGH investigator Ruanne Barnabas - AACR 2022: Understanding cancer's brain is new microenvironment frontier
04/13/2022: BioWorld coverage of presentation by MGH physician William Hwang - Decentralized Clinical Trials: Bringing Care Directly to Patients
04/12/2022: Oncology Nursing News quotes senior clinical research nurse Elizabeth Abraham - BLOG: Three women in oncology look forward to running the 126th Boston Marathon
04/12/2022: Healio quotes MGH physicians Amy Comander, Gabriela Hobbs and Sadhna Vora - Revolutionary leukemia treatment offers 'a hopeful moment' in fight against solid tumors
04/10/2022: USA Today quotes MGH physician Marcela Maus - CT lung cancer screening saved more than 10K lives
04/08/2022: AuntMinnie.com coverage of study led by MGH researcher Alexandra Potter - Could HIV meds help slow advanced cancers?
04/07/202: HealthDay News coverage of research led by MGH investigator David Ting - Massachusetts General Hospital Researchers Develop Tool for Detecting Lung Cancer from the Metabolites in a Drop of Blood
04/04/2022: DARK Daily coverage of study co-led by MGH investigator Leo Cheng - COVID-19 took toll on minority women's mammography screening uptake
04/04/2022: AuntMinnie.com coverage of study led by MGH physician Constance Lehman - Sam Klempner, MD, Reviews ctDNA Role in Gastroesophageal Cancers
04/04/2022: Cancer Network interview with MGH physician Sam Klempner - Radiologists should include radiation oncologists in multidisciplinary workup for pulmonary nodules
04/04/2022: Radiology Business coverage of MGH study - USPSTF's Lung Cancer Screening Recs Tied to Thousands Fewer Deaths
04/01/2022: Medpage Today coverage of study led by MGH physician Chi-Fu Jeffrey Yang - An Overview of Differentiated Thyroid Cancer
03/31/2022: Cure Today interview with MGH physician Lori Worth - New options for HR-Positive breast cancer patients
03/29/2022: MedPage Today video commentary from Mass General Cancer Center physician Aditya Bardia - Sun Exposure and Melanoma, Sun-Seeking, and Sun Protection: Fact and Fiction
03/27/2022: Dermatology Times features MGH physician David Fisher - A Massachusetts mother shares her breast cancer treatment journey - and hope for the future
03/25/2022: WCVB interview with MGH physician Beverly Moy - AI Model May Identify Thyroid Cancer from Ultrasound Images
03/16/2022: HealthDay coverage of study by MGH investigator Rahul Paul - Multimodal Treatment for urothelial cancer
03/15/2022: Targeted Oncology video presentation by Mass General Cancer Center physician Sophia Kamran - Cancer patients fight insurers for coverage of proton beam therapy
03/15/2022: News4 quotes Mass General Cancer Center physician Anthony Zietman - Utilizing endocrine therapy in breast cancer
03/14/2022: Onc Live video presentation with Mass Cancer Center physician Aditya Bardia - BLOG: Reflections on the COVID-19 pandemic
03/08/2022: Healio piece authored by Mass General Cancer Center physician Amy Comander - Colorectal Cancer Trials Enrolling Now: Could Your Patients Benefit?
03/08/2022: Medscape mentions study held at MGH - AI Model May Aid in Screening, Staging, and Treatment Planning for Thyroid Cancer
03/03/2022: The ASCO Post coverage of study led by Mass General Cancer Center investigator Annie Chan - Cancer patients impacted by National blood/platelet shortage
03/03/2022: Boston 25 features MGHfC physician Howard Weinstein - Massachusetts General Hospital to Co-Develop VR Digital Therapeutic for Stem Cell Patients
03/02/2022: HIT Consultant features MGH - ‘Tremendous Hope’ Surrounds Emerging Therapies for Cancer That has Spread to the Brain
03/01/2022: Cure quotes Mass General Cancer Center physician Priscilla Brastianos - Fewer Breast Cancers May Be 'Overdiagnosed' by Mammograms Than Thought
03/01/2022: Health Day quotes MGH physician Katrina Armstrong - Testicular Cancer Deaths Rising Among Hispanic Men
02/28/2022: Medscape coverage of study co-authored by MGH investigator Anushka Ghosh - Doctors Can Be Key to Higher COVID Vaccination Rates
02/28/2022: U.S. News & World Report quotes Mass General Cancer Center physician Andrew Chan - AI platform predicts thyroid cancer, pathologic stage, BRAF status using ultrasound images
02/25/2022: Hem/Onc Today coverage of study led by Mass General Cancer Center investigator Annie Chan - Adding Darolutamide Ups Survival in Metastatic Prostate Cancer
02/23/2022: Health Day coverage of study led by Mass General Cancer Center investigator Matthew Smith - Doctors urge the resumption of preventive care that was stopped during COVID
02/21/2022: NPR features MGH physician Connie Lehman - Representation of women in oncology improving, but some groups still lag behind
02/18/2022: Healio quotes Mass General Cancer Center physician Sophia Kamran - Massachusetts hospital treats 11-year-old from Bangladesh for rare eye cancer
02/17/2022: WCVB features Mass General Cancer Center patient care, quotes Mass General Cancer Center physician Lori Wirth - The Importance of Primary Care Providers in COVID-19 Vaccination
02/10/2022: HCP Live coverage of study led by Mass General Cancer Center investigator Andrew Chan - Chinese Trial Data Won't Cut It for Lung Cancer Drug, FDA Panel Says
02/10/2022: MedPage Today quotes Mass General Cancer Center physician Ibiayi Dagogo-Jack - Vaccine hesitancy or lack of access? New study examines racial gaps in COVID vaccination rates
02/07/2022: WBUR coverage of study led by Mass General Cancer Center investigator Andrew Chan - One-quarter of oncologists uncomfortable with patients recording visits
02/04/2022: HemOnc Today coverage of study led by MGH investigator Rachel B. Jimenez - Scituate woman starts MGH charity with personal touch
02/03/2022: WickedLocal.com features Mass General Cancer Center nurse Laura White and Caring for a Cure - Dr. Klempner on the Results of the DisTinGuish Trial in Advanced Gastroesophageal Adenocarcinoma
02/01/2022: OncLive features Mass General Cancer Center investigator Sam Klempner - Willing but unable to get COVID shot
02/01/2022: The Harvard Gazette coverage of study led by Mass General Cancer Center physician Andrew Chan - FDA Grants Breakthrough Device Designation for BNT200 in Acute Myeloid Leukemia
02/01/2022: Cancer Network quotes Mass General Cancer Center physician Areej El-Jawahri, MD - Dual HER2 Therapy Active in Previously Treated Lung Cancer
01/27/2022: MedPage Today coverage of study co-authored by Mass General Cancer Center investigators Alissa Cooper and Justin Gainor - DTx Receives FDA’s Breakthrough Device Designation for Anxiety and Depression Symptoms Associated With Cancer
01/27/2022: Psychiatric Times coverage of study led by MGH investigator Areej El-Jawahri - Side Effects From New Cancer Meds Have Silver Lining
01/20/2022: Health Day coverage of study co-authored by MGH investigator Yevgeniy Semenov - Diagnosed with Non-Small-Cell Lung Cancer? Here’s Why You Need Biomarker Testing
01/18/2022: Everyday Health quotes MGH physician Zofia Piotrowska - Association Found Between Occurrence of Cutaneous Immune-Related AEs and Response to Immunotherapy and Survival
01/14/2022: Cancer Network coverage of study co-authored by MGH investigator Yevgeniy R. Semenov - FDA grants breakthrough device designation to BNT200 for anxiety in acute myeloid leukemia
01/11/2022: Healio coverage of study led by MGH investigator Areej El-Jawahri - How a team of doctors is eyeing equity when it comes to colon cancer
01/11/2022: Boston.com quotes MGH physician Jennifer Haas - Twins launch charity after surviving breast cancer
01/10/2022: Boston 25 mentions Mass General Cancer Center - Maternity leave as an oncologist characterized by guilt, need to set boundaries
01/07/2022: HemOnc Today features Mass General Cancer Center physician Aparna Parikh - Oral Elacestrant Requires Patient Education in Metastatic ER+ Breast Cancer
01/05/2022: Oncology Nursing News features presentation by Mass General Cancer Center physician Aditya Bardia
2021 Media Coverage
- Communication, education key to optimal management of chronic myeloid leukemia
12/27/2021: Healio features MGH physician Gabriela Hobbs - Clinical Challenges: Specialist Palliative Care in Acute Myeloid Leukemia
12/22/2021: MedPage Today quotes MGH physician Areej El-Jawahri - No Higher Risk of Digestive Cancers in Non-Celiacs Who Eat Gluten
12/22/2021: Celiac.com mentions study led by MGH investigator Andrew Chan - Artificial Intelligence aids in mammogram detection and prediction of breast cancers
12/21/2021: Washington Post quotes MGH physician Connie Lehman - CAR-T therapy combined with gut microbiome therapy may prove beneficial
12/20/2021: STAT News quotes Mass General Cancer Center investigator Matthew Frigault - Thyroid cancer study shows Larotrectinib beneficial to some patients with thyroid cancer
12/20/2021: Targeted Oncology features video presentation with MGH physician Lori Wirth - Study on trial results for endpoint boven therapy in CLL
12/20/2021: Pharmacy Times features video presentation with Mass General Cancer Center investigator Jacob Soumerai - Classifying Thyroid Cancer
12/17/2021: OncLive features Mass General Cancer Center physician Lori Wirth - Prognostic Awareness Impacts QOL in Patients With Myeloma
12/16/2021: Oncology Nursing News coverage of presentation led by Mass General Cancer Center investigator Betsy O’Donnell - Identify feelings, act on behalf of others to address survivor guilt in cancer
12/16/2021: Healio quotes Mass General Cancer Center physician Jeffrey Peppercorn - Conversations about goals of care often occur too late in high-risk AML
12/11/2021: Healio quotes MGH physician Hannah Abrams - New Hormonal Pill May Boost Outcomes for Older Breast Cancer Patients
12/07/2021: Health Day coverage of study led by Mass General Cancer Center investigator Aditya Bardia - Tamoxifen for Primary Breast Cancer May Increase PI3K Signaling and Secondary Uterine Cancer Risk
12/07/2021: Cancer Network coverage of study co-authored by MGH investigator Kirsten Kübler - Racial, ethnic minority populations underrepresented in precision oncology studies
12/02/2021: Healio coverage of study led by MGH investigator Sophia C. Kamran - Cancer Survivors Want Their Sexy Back…but Are Afraid to Ask
12/1/2021: Medscape quotes Mass General Cancer Center physician Areej El-Jawahri - Dr. Chen on Risk Factors for Developing cGVHD
12/1/2021: OncLive features /Mass General Cancer Center physician Yi-Bin Chen - Reduction in Cancer Screenings During COVID-19 May Lead to More Late-Stage Disease, Poorer Outcomes
11/29/2021: Cancer Network coverage of study co-authored by MGH investigator Marc Succi - Expert Talks the Who, What and When of Breast Cancer Genetic Testing
11/24/2021: CURE features Mass General Cancer Center physician Leif Ellisen - Diet That Promotes Sulfur-Metabolizing Bacteria Tied to Colorectal Cancer Risk
11/23/2021: Medscape quotes Mass General Cancer Center physician Andrew Chan - Exeter Hospital Cancer Care receives $1 million gift from grateful patient
11/22/2021: Seacoastonline quotes Mass General Cancer Center physician Panagiotis Fidias - Overview of Advanced NSCLC with EGFR Mutations Including Exon 20 Insertions
11/18/2021: Cancer Network Features Mass General Cancer Center physician Zofia Piotrowska - Liver Cancer Risk Lingers Even After HCV Eradication
11/17/2021: Medscape quotes Mass General Cancer Center physician Raymond Chung - Treatment Landscape for HER2+ Metastatic Breast Cancer
11/16/2021: Cancer Network features Mass General Cancer Center physician Aditya Bardia - ‘Better biomarkers are needed’ as treatment options for advanced melanoma increase
11/15/2021: HemOnc Today quotes Mass General Cancer Center physician Ryan Sullivan - More Evidence That COVID Vaccines Are Safe for Cancer Patients
11/12/2021: U.S. News & World Report coverage of study co-authored by Mass General Cancer Center investigator Justin Gainor - Case Overview: 82-Year-Old Man With Metastatic CRPC
11/10/2021: Targeted Oncology features Mass General Cancer Center physician Matthew Smith - Long-Term Benefit With Abemaciclib in High-Risk Early Breast Cancer
11/05/2021: Cancer Therapy Advisor quotes Mass General Cancer Center physician Aditya Bardia - Skin Checks Reduce All-Cause but Not Melanoma-Specific Deaths
11/03/2021: Medscape quotes MGH physician Shawn Demehri - Ivosidenib Continues To Show Benefit for Patients with IDH1-Mutant Cholangiocarcinoma
11/03/2021: Oncology Nursing News coverage of study co-authored by Mass General Cancer Center investigator Andrew Zhu - Percutaneous Image-Guided Microwave And Cryoablation For Lung Sarcoma
10/31/2021: Medical Dialogues coverage of study led by MGH investigator Florian Fintelmann - Heterogeneity of GVHD
10/29/2021: Cancer Network features Mass General Cancer Center physician Yi-Bin Chen - New Drug Approvals Expand cGVHD Treatment Beyond Steroids, But Real-World Data Still Needed
10/29/2021: Oncology Nursing News quotes Mass General Cancer Center physician Yi-Bin Chen - cGVHD Paradigm Gains Systemic Options Beyond Steroids, But Real-World Data Are Required
10/27/2021: OncLive features Mass General Cancer Center physician Yi-Bin Chen - Gene Test Finds Gradations in High-Risk Prostate Cancer
10/26/2021: MedPage Today quotes Mass General Cancer Center physician Sophia Kamran - Social Support Improves Survival in Patients With Blood Cancers
10/26/2021: Medscape coverage of study co-authored by Mass General Cancer Center investigator Patrick Johnson - Potential New Standard for Post-Prostatectomy Radiotherapy
10/25/2021: MedPage Today quotes Mass General Cancer Center physician Sophia Kamran - Becoming an Informed Patient With Rare Cancer
10/25/2021: Cure features Q&A with Mass General Cancer Center physician Gabriela Hobbs - New thinking on aspirin and colorectal cancer needs dose of nuance, expert says
10/22/2021: Harvard Gazette features Q&A with Mass General Cancer Center physician Andrew Chan - First Oral SERD Elacestrant Achieves Positive Findings in EMERALD Trial for ER+/HER2– Advanced or Metastatic Breast Cancer
10/21/2021: Cancer Network quotes Mass General Cancer Center physician Aditya Bardia - Analysis Confirms Benefits of CDK4/6 Inhibition in Early Breast Cancer
10/20/2021: MedPage Today coverage of study co-authored by Mass General Cancer Center Investigator Aditya Bardia - Elacestrant Improves PFS Over SOC in ER+ Advanced or Metastatic Breast Cancer
10/20/2021: OncLive coverage of study co-authored by Mass General Cancer Center Investigator Aditya Bardia - New Mechanisms Under Study to Overcome Osimertinib Resistance in EGFR+ NSCLC
10/18/2021: Targeted Oncology coverage of study co-authored by Mass General Cancer Center investigator Lecia Sequist - Treating Post-MPN Acute Leukemia Remains an Unmet Medical Need
10/18/2021: Targeted Oncology features Mass General Cancer Center physician Gabriela Hobbs - Upfront Triplet Improves OS in Metastatic Castration-Sensitive Prostate Cancer
10/18/2021: MedPage Today coverage of study co-authored by Mass General Cancer Center investigator Xin Gao - New Drug for TNBC
10/15/2021: Medscape coverage of study led by Mass General Cancer Center investigator Aditya Bardia - When Breast Cancer Gets Personal
10/13/2021: ABR blog post by Mass General Cancer Center radiation oncologist Alice Y. Ho, MD, MBA - Scientists uncover answer to colorectal cancer immunotherapy resistance
10/13/2021: Drug Target Review coverage of study co-authored by MGH investigators - Harvard Scientists’ Study Sheds Light on Brain Tumor Resiliency
10/13/2021: The Harvard Crimson coverage of study co-authored by MGH investigator Mario Suvà - Percutaneous Image-Guided Microwave and Cryoablation for Lung Sarcoma
10/11/2021: Imaging Technology News coverage of study co-authored by MGH investigator Florian Fintelmann - After stage 4 cancer diagnosis, Judie Potter is running Boston
10/08/2021: Boston.com features MGH patient and marathon runner - Don't panic if you get swollen lymph nodes after a vaccine booster. But be aware if you're due for a mammogram, doctors say
10/08/2021: CNN quotes MGH chief of breast imaging division Connie Lehman - It Takes a Village: Cancer Caregivers Need to Care for Themselves, Too
10/07/2021: Cure coverage of study led by Mass General Cancer Center investigator Elizabeth O’Donnell - Uncovering DNA Methylation Details in Brain Cancer
10/05/2021: Technology Networks coverage of study co-authored by MGH investigator Mario Suva - New treatments are changing the lives of people with breast cancer. And the future holds greater promise
10/04/2021: Yahoo! News/USA Today quotes Mass General Cancer Center physician Steven Isakoff - Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 36th Anniversary Annual Meeting
10/04/2021: Yahoo! Finance features Mass General Cancer Center physician Sara Pai - Advanced technique offers new insights about the dynamics of gliomas
10/02/2021: News Medical Life Sciences coverage of study co-authored by MGH investigator Mario Suva - Sarcoma Highlights From ESMO 2021
09/30/2021: MedPage Today features Mass General Cancer Center investigator Edwin Choy - What Pancreatic Cancer Researchers Can Learn from the Patient’s Voice
09/28/2021: Pancreatic Cancer Action Network coverage of study co-authored by Mass General Cancer Center physician Ryan Nipp - Mooradian Compares IMpower133 and CASPIAN Trials in ES-SCLC
09/28/2021: Targeted Oncology features roundtable meeting led by Mass General Cancer Center physician Meghan Mooradian - Everything You Need (And Need To Know) For Breast Cancer Awareness Month
09/28/2021: Boston Magazine features Mass General Cancer Center physician Sadhna Vora - The Importance of Patient-Reported Outcomes in The LIBRETTO-001 Trial
09/23/2021: Targeted Oncology features presentation by Mass General Cancer Center physician Lori Wirth - BMI a key clue to catching interval cancers between mammography screenings, large study finds
09/16/2021: Radiology Business coverage of study co-authored by MGH investigators - Real-Time Mammography Reading Cuts Disparities in Diagnostic Imaging
09/15/2021: HealthDay coverage of study co-authored by MGH investigator Brian Dontchos - How Does the Immune System Fight Cancer?
09/13/2021: Cancer Health quotes Mass General Cancer Center physician Marcela Maus - Enzalutamide Shown to Slow Progression of Localized Prostate Cancer
09/13/2021: Renal & Urology News quotes Mass General Cancer Center physician Adam Feldman - Partial, Radical Cystectomy for MIBC Yield Similar Survival Outcomes
09/13/2021: Renal & Urology News quotes Mass General Cancer Center physician Matthew Wszolek - Metabolic Syndrome Post-Prostatectomy Ups Prostate Cancer Death Risk
09/12/2021: Renal & Urology News quotes Mass General Cancer Center physician Keyan Salari - Which Patients Benefit Most From Adjuvant Atezolizumab in NSCLC?
09/11/2021: Medscape quotes MGH physician Zofia Piotrowska - Meet the medical professionals fighting COVID-19 misinformation on TikTok: 'A lot of people just need to be empowered'
09/09/2021: Yahoo! Life quotes Mass General Cancer Center nurse Christina Kim - Study Identifies How PARP Inhibitors Fight BRCA1, BRCA2 Tumor Cells
09/08/2021: Pharmacy Times coverage of study co-authored by Mass General Cancer Center investigator Zou Lee - Ensartinib Tops Crizotinib in ALK-Positive NSCLC
09/02/2021: MedPage Today features accompanying editorial authored by Mass General Cancer Center physician Ibiayi Dagogo-Jack - Adjuvant Giredestrant Goes Up Against Third-Generation Endocrine Therapies in ER+/HER2- Early Breast Cancer
09/01/2021: Targeted Oncology coverage of study led by Mass General Cancer Center investigator Aditya Bardia - 5 for Good: Marblehead mother raises money to fight rare cancers
08/26/2021: WCVB coverage of fundraising benefitting the Henri and Belinda Termeer Center for Targeted Therapies at Mass General Cancer Center, features physician Lipika Goyal - The Future of Selpercatinib in the RET-Altered Thyroid Cancer Population
08/26/2021: Targeted Oncology coverage of presentation by Mass General Cancer Center physician Lori Wirth - Scientists discover how triple-negative breast cancer can defeat powerful drugs
08/23/2021: WGNO coverage of study co-authored by Mass General Cancer Center investigator Leif Ellisen - Why LeVar Burton Is Encouraging People to Boldly Go Back to the Doctor
08/23/2021: Healthline features MGH physician Gaby Hobbs - Collaborative Intervention for Lung Cancer Screening May Improve Health Equity Among People with Serious Mental Illness
08/19/2021: Diagnostic Imaging coverage of study led by MGH investigator Efren Flores - Resistance to Drug for Triple-Negative Breast Cancer Identified
08/18/2021: Genetic Engineering & Biotechnology News coverage of study led by MGH investigators Aditya Bardia and Leif Ellisen - Scientists discover how triple-negative breast cancer can defeat powerful drugs
08/17/2021: WANE.com coverage of study led by MGH investigators Aditya Bardia and Leif Ellisen - Scientists identify mechanisms of resistance to drug for triple-negative breast cancer
08/17/2021: Mirage News coverage of study co-authored by Mass General Cancer Center physicians Leif Ellisen and Aditya Bardia - Researchers identify skin darkening enzyme that could help prevent skin cancers
08/12/2021: Healio coverage of study co-authored by MGH investigator David Fisher - No Survival Boost With Hypofractionated Image-Guided RT for NSCLC
08/12/2021: MedPage Today article features commentary by MGH physicians Melin Khandekar and Florence Keane - How Immune Cells Survive Cancer Battles
08/12/2021: Harvard Medical School coverage of study co-authored by MGH investigators - Are Delta Symptoms Different?
08/12/2021: New York Times features Mass General Cancer Center physician Andrew Chan - CEACAM5 Joins a Growing Menu of Emerging Lung Cancer Targets
08/03/2021: OncLive features Mass General Cancer Center physician Justin Gainor - Life With von Hippel-Lindau Disease
08/03/2021: Cure quotes Mass General Cancer Center physician Othon Iliopoulos - How Boston Doctors Are Working to Get Breast Cancer Screening Results to Women Faster
07/29/2021: NBC Boston features MGH mammogram screening program and chief of breast imaging division Connie Lehman - Dr. Gainor on the Potential Value of Targeting TROP-2 and CEACAM5 in Lung Cancer
07/23/2021: OncLive features presentation by Mass General Cancer Center physician Justin Gainor - Keep some pandemic-initiated changes to cancer clinical trials, task force members urge
07/22/2021: Healio features Mass General Cancer Center investigator Keith Flaherty - Unique Immunotherapy Combos Evaluated in Advanced Melanoma
07/20/2021: Targeted Oncology features poster session by MGH investigator Meghan Mooradian - Immune checkpoint inhibitors linked to rapid eGFR decline, development of kidney disease
07/19/2021: Healio coverage of study co-authored by MGH investigator Donald Chute - Researchers discover how cancer cells that spread to lymph nodes avoid immune destruction
07/19/2021: Medical Xpress coverage of study co-authored by MGH investigator Timothy Padera - George Labonte: Concerns Upon a Diagnosis of Medullary Thyroid Cancer
07/14/2021: Cure mentions patient treatment by MGH physician Lori Wirth - Smoking exposure may predict immune checkpoint inhibitor efficacy in advanced NSCLC
07/12/2021: Healio coverage of study co-authored by Mass General Cancer Center investigator David C. Christiani - Historical Perspective on Treatment of Gastric and GEJ Cancers
07/12/2021: OncLive features presentation by MGH physician Sam Klempner - ‘This is a godsend’: Doctors, spurred by the pandemic, try to make breast cancer screening easier and faster
07/10/2021: Boston Globe mentions patient care at MGH, quotes Breast Imaging director Constance Lehman - A look at post-traumatic stress in cancer survivors
07/08/2021: Mass Appeal features presentation by MGH psychologist Lara Traeger - Addressing Moral Distress and Burnout in Oncology
07/07/2021: Targeted Oncology coverage of presentation by Mass General Cancer Center investigator Lara Traeger - Skin pigmentation mechanism confers major protection against UV-related cancers
07/07/2021: News Medical Life Sciences coverage of study co-authored by MGH investigator David Fisher - The field of exercise oncology is bringing benefits, hope to survivors of breast cancer
07/06/2021: Harvard Medicine features MGH investigator Elizabeth O’Donnell - Preventing UV-associated cancers by altering skin pigmentation
07/06/2021: The Harvard Gazette coverage of study co-authored by MGH investigator David Fisher - Promising Antitumor Activity for Datopotamab Deruxtecan in TNBC
07/06/2021: Targeted Oncology coverage of oral presentation by Mass General Cancer Center investigator Aditya Bardia - Role of Molecular Profiling in HR+ Metastatic Breast Cancer
06/30/2021: OncLive video features MGH investigators Aditya Bardia and Dejan Juric - Overview and Diagnosis of Differentiated Thyroid Cancer
06/25/2021: Targeted Oncology features MGH investigator Lori Wirth - Diving Deeper Into Benefit of Avelumab Maintenance in Bladder Cancer
06/24/2021: MedPage Today features MGH physician Xin Gao - Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA
06/24/2021: MedPage Today quotes MGH physician Colin Weekes - Harnessing the immune response against common moles to combat melanoma
06/23/2021: Fierce Biotech coverage of study led by MGH investigators - Clinical Challenge: Optimal Therapies for Rare EGFR Mutations in NSCLC
06/22/2021: MedPage Today quotes MGH investigator Zofia Piotrowska - Mass General Researchers Reveal New Strategies for Treating Resistant Cancers
06/22/2021: Clinical OMICs coverage of study led by MGH investigator Kaiwen Li - Intralesional Therapies Help Bridge the Gap Between Improved Results and Less Toxicity
06/15/2021: Cure quotes MGH physician Genevieve Boland - Lack of Vitamin D May Increase Risk of Opioid Addiction, and Sun-Seeking Behavior
06/15/2021: Genetic Engineering & Biotechnology News coverage of study led by MGH investigator Lajos Kemény, mentioning work of investigator David Fisher - Zandelisib/Zanubrutinib Combination in R/R CLL and B-Cell Malignancies Shows Clinical Benefit
06/12/2021: Cancer Network coverage of presentation by MGH investigator Jacob Soumerai - Raising Awareness About Gastric Cancer in Young Adults
06/11/2021: Cure features MGH investigator Sam Klempner - Importance of Clinical Trials for Gastric Cancer
06/11/2021: Cure features MGH investigator Sam Klempner - Comprehensive Genomic Profiling in Lung and Thyroid Cancer
06/08/2021: Cure features MGH investigator Lori Wirth - New Evidence Suggests COVID-19 Vaccines Remain Effective Against Variants
06/09/2021: NPR/Shots quotes MGH investigator Marcela Maus - CAR-T with synthetic binder shows ‘very promising’ results in advanced multiple myeloma
06/08/2021: HemOnc Today coverage of study led by MGH investigator Matthew Frigault - Prior Therapy Does Not Influence Selpercatinib Efficacy in RET+ Medullary Thyroid Cancer
06/08/2021: Cancer Network coverage of study led by MGH investigator Lori Wirth - Novel CART-ddBCMA Leads to 100% Response Rate in First-in-Human Myeloma Trial
06/07/2021: Cancer Network coverage of study led by MGH investigator Matthew Frigault - Selpercatinib Improves Responses Regardless of Immediate Prior Treatment in RET-Mutant Medullary Thyroid Cancer
06/06/2021: OncLive coverage of study led by MGH investigator Lori Wirth - CART-ddBCMA Shows Significant ORR in Relapsed/Refractory Multiple Myeloma
06/06/2021: Targeted Oncology coverage of study led by MGH investigator Matthew Frigault - CAR-T Drives High Response in Relapsed/Refractory ALL
06/06/2021: MedPage Today mentions comment authored by MGH investigator Marcela Maus - Selpercatinib Improves Responses Regardless of Prior Treatment in RET-Mutant Medullary Thyroid Cancer
06/06/2021: Targeted Oncology coverage of study led by MGH investigator Lori Wirth - Immunotherapy Likely New Standard in Advanced Esophageal Cancer
06/03/2021: Medscape quotes MGH investigator Samuel Klempner - CRC Screening Guidelines: 45 Is the New 50, and 85 Is the New 75
06/03/2021: Medscape mentions study led by MGH investigator Andrew Chan - Practice Halt: No Benefit in Cervical Cancer With Adjuvant Chemo
06/03/2021: Medscape quotes Mass General Cancer Center Medical Gynecologic Oncology clinical director Richard Penson - Roundtable Discussion: Panel Explains the Different Treatment Options in Nonmetastatic CRPC
05/27/2021: Targeted Oncology coverage of panel discussion led by MGH investigator Matthew Smith - Colonoscopy, Unloved Ritual of Turning 50, Moves 5 Years Earlier
05/25/2021: Bloomberg mentions study led by MGH investigator Andrew Chan - Colonoscopy After 75: A Potential Lifesaver for Most
05/21/2021: HealthDay coverage of study co-authored by MGH investigator Andrew Chan - The Mighty Quinn Serves As Bruins’ Banner Captain Amid News His Tumors Are Shrinking
05/19/2021: CBS Boston mentions patient care at Mass General Cancer Center - When cancer took her hair, this artist found locks to laugh about
05/19/2021: Boston Globe mentions patient care and art exhibition at Mass General Cancer Center - Medical World News After Hours: Oncologist Amy Comander, MD, Discusses Marathon Running and Motivation
05/15/2021: Cancer Network features MGH physician Amy Comander - Impressive Disease Control in Metastatic Triple-Negative Breast Cancer
05/14/2021: MedPage Today coverage of presentation by MGH investigator Aditya Bardia - Improvements in Diet, Physical Activity Through a Lifestyle Clinic May Improve Outcomes in Patients With a History of Cancer
05/13/2021: Cure Today coverage of presentation by MGH investigator Loren Winters - While empowering patients, oncology open notes may add to physician workload
05/10/2021: HemOnc Today quotes MGH Breast Oncology Program clinical director Beverly Moy - Datopotamab Deruxtecan Shows Promise in Heavily Pretreated Triple-Negative Breast Cancer
05/10/2021: Cancer Network coverage of study led by MGH investigator Aditya Bardia - Medical World News® After Hours: Nurse Practitioner Loren Winters Discusses Staying Balanced With Yoga and Ayurveda
05/08/2021: Cancer Network features MGH Center for Breast Cancer nurse practitioner Loren Winters - Datopotamab Deruxtecan Shows Encouraging Preliminary Safety, Efficacy in TNBC
05/08/2021: OncLive coverage of study led by MGH investigator Aditya Bardia - These Doctors are Using AI to Screen for Breast Cancer
05/05/2021: OncologyTube features MGH Breast Imaging director Constance Lehman - Pfizer/BioNTech and Moderna vaccines induce T-cell immunity against SARS-CoV-2
05/05/2021: News Medical coverage of study led by MGH investigator Marcela Maus - Deeper Dives Into the Bone Marrow Microenvironment of Myeloma Cells Provide New Insights Into Novel Therapies and Disease Biology
05/04/2021: Cancer Therapy Advisor quotes MGH Center for Multiple Myeloma director Noopur Raje - Telehealth visits for lifestyle medicine less burdensome for cancer survivors
05/03/2021: HemOnc Today coverage of presentation by MGH investigator Loren Winters - First “Tumor Uninformed” Cancer Recurrence Test Evaluated at Mass General
05/03/2021: Clinical OMICs coverage of study led by MGH investigator Aparna Parikh - Do I Have to Get the Covid Vaccine in My Arm?
04/29/2021: New York Times quotes MGH Lymphedema Research Program associate director Cheryl Brunelle and director Alphonse Taghian, and Breast Imaging director Constance Lehman - Triple Negative Breast Cancer: Trodelvy® (Sacituzumab Govitecan) Trial Demonstrates Significant Improvement Compared To Standard Chemo
04/22/2021: MedicalResearch.com interview with MGH investigator Aditya Bardia - Altering Diet, Physical Activity in Patients With Cancer History May be Aided by Lifestyle Medicine Clinics
04/20/2021: Cancer Network coverage of presentation by MGH investigator Loren Winters - Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
04/20/2021: HealthDay coverage of study co-authored by MGH investigator Shannon Wongvibulsin - Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product
04/12/2021: Medscape quotes MGH investigator Howard Kaufman - COVID-19 Vaccine Can Cause False Positive Cancer Diagnosis
04/09/2021: Imaging Technology News coverage of study led by MGH investigator Constance Lehman - FDA Approves Sacituzumab Govitecan for Adults with Triple-Negative Breast Cancer
04/08/2021: Pharmacy Times coverage of study led by MGH investigator Aditya Bardia - Virtual Event: What gene-targeted therapies mean for patients with cancer
04/08/2021: STAT panel features MGH physician Laura Petrillo - Myeloma Therapies Create an ‘Optimistic Picture’ for Patients’ Futures
04/06/2021: Cure Today interview with MGH physician Andrew Yee - Sacituzumab Shines in ASCENT TNBC Trial
04/05/2021: Clinical Oncology coverage of study led by MGH investigator Aditya Bardia - Muscle Health Associated With Symptom Burden, Clinical Outcomes, Survival, in Advanced Cancer
04/01/2021: Oncology Nurse Advisor coverage of study by MGH investigators - Futibatinib Earns Breakthrough Therapy Designation for FGFR2+ Cholangiocarcinoma
04/01/2021: Cancer Network coverage of presentation by MGH investigator Lipika Goyal - Multiple Trial Regimens Demonstrate Efficacy for RET-Mutated Medullary Thyroid Cancer
03/31/2021: Targeted Oncology quotes MGH Center for Head and Neck Cancers medical director Lori Wirth - ‘Significant Unmet Needs’ Not Addressed With FDA Approval of Lorbrena
03/31/2021: Cure Today quotes MGH Center for Innovation in Early Cancer Detection director Lecia Sequist - YOUR HEALTH: A drug used for aggressive cancers
03/31/2021: WQAD8 (Ill.) quotes director of Precision Medicine at the Center for Breast Cancer at Mass General Cancer Center Aditya Bardia - How Cancer Immunotherapy Gets a STING
03/29/2021: Genetic Engineering & Biotechnology News coverage of study co-authored by MGH investigator Mariko Takahashi - Voices of Hope Donates $55K to MGH for 2020!
03/24/2021: Boston Patch coverage of donation to Henri and Belinda Termeer Center for Targeted Therapies at Mass General Cancer Center - Cancer symposium connects generations around immunotherapy treatment
03/22/2021: The Globe and Mail coverage of The Arthur and Sandra Irving Cancer Immunology Symposium held at Mass General Cancer Center. - Cancer Patients Respond Poorly to First COVID mRNA Vax Dose
03/19/2021: MedPage Today quotes MGH investigator Justin Gainor - Mindfulness Can Decrease Anxiety and Build Resiliency in Cancer Survivors
03/18/2021: Cure Today interview with MGH Center for Breast Cancer nurse practitioner Loren Winters - The Basics of Multiple Myeloma
03/18/2021: Cure Talks Cancer podcast features MGH physician Andrew Yee - Drawing Actionable Information From the Blood in Advanced Biliary Tract Cancer
03/17/2021: OncLive mentions study led by MGH investigator Lipika Goyal - GVHD Prophylaxis: Similar Outcomes With PTCy and ATG
03/17/2021: Medscape quotes MGH investigator Zachariah DeFilipp - Diet and Exercise Can Play an Important Role in Breast Cancer Survivors
03/17/2021: Cure Today interview with Mass General Cancer Center physician Amy Comander - Emerging Therapies Show Promise in Treating Metastatic Breast Cancer
03/16/2021: Cure Today interview with MGH investigator Neelima Vidula - How Targeted Therapies Are Changing the Breast Cancer Treatment Landscape
03/11/2021: Cure Today interview with MGH Termeer Center for Targeted Therapies director Dejan Juric - Mindfulness Is Beneficial to Patients and Providers
03/10/2021: Oncology Nursing News interview with MGH Center for Breast Cancer nurse practitioner Loren Winters - Guidelines provide consensus on management of CAR T-cell therapy-related toxicities
03/10/2021: Immuno-Oncology Resource Center coverage of guidelines lead-authored by MGH investigator Marcela Maus - How Patients With Cancer Can Boost Their ‘Mindfulness Muscle’ and Improve Resiliency
03/10/2021: Cure Today quotes MGH Center for Breast Cancer nurse practitioner Loren Winters - Health panel expands lung cancer screening for more smokers
03/09/2021: Associated Press mentions editorial co-authored by MGH investigator Yolonda Colson - ‘Lost in Transition’ After Breast Cancer
03/09/2021: Cure Today quotes MGH physician Jeffrey Peppercorn - Pilot Program to Study Telehealth Value in Advance Care Planning
03/05/2021: mHealth Intelligence coverage of study co-led by MGH investigator Areej El-Jawahri - Are swollen lymph nodes normal after getting the COVID vaccine?
03/03/2021: Open Access Government coverage of study led by MGH investigator Constance Lehman - Woman Fights Back After Insurer Wouldn't Cover Her Cancer Treatment
03/02/2021: NBC Boston coverage of patient treatment at MGH, features Mass General Cancer Center physician Andrea Russo - A Covid Vaccine Side Effect, Enlarged Lymph Nodes, Can Be Mistaken for Cancer
03/01/2021: New York Times coverage of study led by MGH investigator Constance Lehman - Prostate cancer: A tailored approach
02/22/2021: Bay State Banner quotes MGH physician Michael Blute - Symptom Burden, Functional Status of Hospitalized Patients With Genitourinary Cancers vs Other Cancers
02/18/2021: Journal of Clinical Pathways video features MGH investigator Daniel Lage - Darolutamide Remains Well-Tolerated with Prolonged Treatment Among Patients with nmCRPC
02/12/2021: Cancer Network coverage of study led by MGH investigator Matthew Smith - Regular Aspirin Use May Lower Colorectal Cancer Risk
02/11/2021: Cancer Health coverage of study led by MGH investigator Andrew Chan - Family History of Hereditary Cancer May Up PCa Progression Risk on Active Surveillance
02/11/2021: Renal and Urology News coverage of presentation by MGH investigator Keyan Salari - Could AI tools for breast cancer worsen disparities? Patchy public data in FDA filings fuel concern
02/11/2021: STAT quotes MGH physicians Salewa Oseni and Constance Lehman, mentions study led by MGH Laboratory of Computer Science investigators Hossein Estiri and Zachary Strasser - Considerations When Choosing a CAR-T Cell Therapy in Lymphoma
02/09/2021: MedPage Today quotes MGH investigator Jeremy Abramson - FDA Approves Breyanzi for Adults with Relapsed, Refractory Large B-cell Lymphoma
02/08/2021: Pharmacy Times coverage of study led by MGH investigator Jeremy Abramson - Alphonse Taghian and George Naoum on Axillary Surgery, Nodal RT, and Lymphedema
02/02/2021: MedPage Today coverage of study co-authored by MGH investigators Alphonse Taghian and George Naoum - Sequist Calls 2020 a Banner Year in Lung Cancer, But Leaves Much to Be Desired
02/01/2021: OncLive interview with MGH investigator Lecia Sequist - Expert Panel Weighs Practice-Changing Potential of Early Data in EGFR+ NSCLC
01/28/2021: OncLive coverage of panel featuring MGH investigator Zofia Piotrowska - These Doctors Are Using AI to Screen for Breast Cancer
01/27/2021: Wired features MGH investigator Constance Lehman - Better understanding of late effects needed to guide survivorship care after CAR-T Cell Therapy
01/26/2021: Next interview with MGH investigator Areej El-Jawahri - Daily Aspirin Can Lower Colon Cancer Risk, But Age Matters
01/25/2021: HealthDay News coverage of study led by MGH investigator Andrew Chan - Durvalumab, Osimertinib Envelop Adjuvant and Neoadjuvant NSCLC Treatment
01/25/2021: OncLive coverage/ of presentation by MGH investigator Zosia Piotrowska - Aspirin Use Cuts CRC Risk in Those Initiating Use Before Age 70
01/21/2021: HealthDay News coverage of study led by MGH investigator Andrew Chan - Novel Therapy Shows Promise in Liver Cancer Subset, May Address ‘Urgent Need for New Therapies’
01/21/2021: Cure coverage of study led by MGH investigator Andrew Zhu - Emerging Strategies Seek to Build on the Benefit Achieved With Radiation in Lung Cancer
01/19/2021: OncLive features MGH physician Katie Keane - Ivosidenib Produces Encouraging OS Data in Previously Treated Cholangiocarcinoma
01/18/2021: Targeted Oncology features MGH investigator Andrew Zhu - TKIs Set the Stage for Treatment in HER2-Mutant Lung Cancer, But May Be Eclipsed by ADCs
01/14/2021: OncLive interview with MGH investigator Lecia Sequist - How has the pandemic affected cancer research?
01/13/2021: Forbes quotes MGH investigator Erica Warner - Dr. Sullivan on Sequencing Targeted Therapy and Immunotherapy in Melanoma
01/12/2021: OncLive features MGH physician Ryan Sullivan - Foundation awards $2M+ to cancer researchers
01/12/2021: Becker's Hospital Review list includes MGH investigator Alexandra-Chloé Villani - Trials Conducted in Unresectable Locally Advanced Lung Adenocarcinoma Show Path for Treatment
01/09/2021: Targeted Oncology coverage of study led by MGH investigator Zofia Piotrowska - Making the Most of Osimertinib in NSCLC
01/08/2021: MedPage Today coverage of study led by MGH investigator Zofia Piotrowska - CAR T Cells Can Be Toggled On and Off, Say Dana-Farber Research Team
01/07/2021: Clinical OMICs coverage of study co-led by MGH investigator Marcela Maus - Integrated Palliative and Oncology Care for AML Recommended as New Standard of Care
01/05/2021: Journal of Clinical Pathways coverage of study co-authored by MGH investigator Areej El-Jawahri - Impact of CAR T-Cell Therapy on EOL Outcomes
01/04/2021: MedPage Today features MGH investigator Patrick Connor Johnson
2020 Media Coverage
- Matching Novel Targets to Treatment Generates Excitement in TNBC
12/31/2020: OncLive interview with MGH investigator Neelima Vidula - Can deep learning help predict breast cancer?
12/30/2020: Medical Design and Outsourcing coverage of study led by MGH investigator Leslie Lamb - New Clinical Trial In Boston Tests Home Treatment For Cancer Patients
12/28/2020: CBS Boston features Mass General Cancer Center physician Areej El-Jawahri - National Association for Proton Therapy launches physician advisory committee
12/28/2020: HemOnc Today list includes MGH investigator Torunn Yock - Chemoimmunotherapy Combos Push Forward in TNBC Treatment
12/27/2020: Oncology Nursing News coverage of presentation by MGH investigator Neelima Vidula - Coronavirus slowing critical cancer research, screenings
12/21/2020: Boston 25 News quotes MGH physician Rebecca Heist - On the Horizon: Asciminib, a New Drug for Treating R/R CML
12/14/2020: Medscape quotes MGH physician Gabriela Hobbs - Myeloproliferative neoplasm driver mutations often acquired before birth, in childhood
12/11/2020: HemOnc Today includes perspective by MGH investigator Timothy Graubert - PSA Density Kinetics Predict Prostate Cancer Progression on AS
12/09/2020: Cancer Therapy Advisor coverage of study led by MGH investigator Adam Feldman - Asciminib effective, safe as late-line treatment for chronic-phase CML
12/08/2020: HemOnc Today includes perspective by MGH investigator Amir Fathi - Five-Minute SC Injection of Daratumumab in R/R Multiple Myeloma
12/08/2020: Medscape quotes MGH investigator Noopur Raje - Dr Rachel Jimenez: Risk, Nature of Cardiac Toxicity in Breast Cancer Is Variable
12/08/2020: AJMC features MGH physician Rachel Jimenez - In MDS, Transplant Ups Survival in Elderly and May Be Reimbursed
12/04/2020: Medscape quotes MGH investigator Andrew Brunner - NCI-MATCH Trial Identifies Actionable Alterations in More Than One-Third of Patients With Cancer
12/03/2020: Therapy Advisor coverage of study led by MGH investigator Keith Flaherty - Bardia Brings Clinical Scenarios to Light Across Breast Cancer Subtypes
11/30/2020: OncLive features MGH physician Aditya Bardia - MGH breast cancer researchers use AI to spot new details in mammograms
11/30/2020: Fierce Biotech coverage of study led by MGH investigator Leslie Lamb - Dr Aditya Bardia Highlights Immuno-Oncology Developments for Patients With TNBC
11/25/2020: AJMC features MGH investigator Aditya Bardia - Cancer-killing virus escapes immune destruction and fights metastatic lung tumors in mice
11/25/2020: Fierce Biotech mentions MGH study - Lorlatinib surpasses crizotinib as first-line treatment for advanced ALK+ lung cancer
11/18/2020: MD Alert coverage of study led by former Center for Thoracic Cancers at MGH director Alice Shaw - Researchers at Harvard’s Massachusetts General Hospital Develop a Non-Invasive Liquid Biopsy Blood Test to Detect and Monitor Common Brain Tumors in Adults
11/04/2020: Dark Daily coverage of study co-led by investigators Leonora Balaj and Bob Carter - Dr Aditya Bardia: Further Research Is Needed to Understand Resistance to Sacituzumab Govitecan
11/01/2020: AJMC features MGH investigator Aditya Bardia - Autologous vs. allogeneic CAR-T: Decisions must be made ‘carefully and deliberately’
10/28/2020: Cell Therapy Next interview with MGH investigator Marcela Maus - Dr Aditya Bardia Forecasts What’s to Come for the ASCENT Trial in Triple-Negative Breast Cancer
10/25/2020: AJMC features MGH investigator Aditya Bardia - A MicroRNA Region Gives Insight on Lactose Intolerance and Metabolic Diseases
10/24/2020: Science Times quotes MGH investigator Daniel Haber - Lack of Targeted Therapies for NRG1 Fusion-Positive Advanced Solid Tumors Comes to Attention
10/23/2020: Targeted Oncology quotes MGH physician Jessica Jiyeong Lin - Harvard Professors Elected to the National Academy of Medicine
10/22/2020: Harvard Magazine features MGH physicians Yolonda Lorig Colson and David Fisher - Keith T. Flaherty, MD, on NCI-MATCH Supporting NGS to Triage Patients to Investigational Therapy
10/20/2020: CancerNetwork interview with MGH investigator Keith Flaherty - Hunting Resistance Mechanisms in RET-Fusion Lung Cancer
10/18/2020: MedPage Today coverage of presentation by MGH investigator Justin Gainor - Doctors stress importance of breast cancer screenings during pandemic
10/14/2020: WCVB report features MGH physician Connie Lehman - Patient-Reported Outcomes Confirm Tolerability of Selpercatinib in RET-Driven Thyroid Cancer
10/12/2020: Targeted Oncology interview with MGH investigator Lori Wirth - Dr Aditya Bardia on How Combining Sacituzumab Govitecan, Talazoparib Amplifies Treatment Response
10/12/2020: AJMC features MGH investigator Aditya Bardia - Lisocabtagene maraleucel could be ‘CAR T-cell treatment of choice’ for lymphoma subset
10/08/2020: HemOnc Today coverage of study co-authored by Jeremy Abramson - Aditya Bardia, MD, MPH, on Triple-Negative Breast Cancer: Sacituzumab Govitecan vs Treatment of Physician’s Choice
10/07/2020: The ASCO Post features MGH investigator Aditya Bardia - OncLive Honors 15 Cancer Care Pioneers
10/06/2020: OncLive list includes MGH investigator Keith Flaherty - ILCA Data Reignite Interest in AFP as a Biomarker for HCC
10/04/2020: Targeted Oncology coverage of presentation by MGH investigator Andrew Zhu - NSCLC Treatment Portfolio Gains RET-Targeted Therapy
10/01/2020: OncologyLive features MGH physician Justin Gainor - Dr Aditya Bardia Discusses the Advantages of Sacituzumab Govitecan for Triple-Negative Breast Cancer
09/28/2020: AJMC features MGH investigator Aditya Bardia - Should AI interpretation of mammograms become widespread in clinical practice?
09/25/2020: HemOnc Today opinion co-authored by MGH investigator Constance Lehman - Getting to the heart of CAR T-cell therapy’s cardiovascular risks
09/25/2020: Cell Therapy Next quotes MGH investigator Matthew Frigault - I knew getting prostate cancer at 48 would change me. I had no idea how much.
09/24/2020: The Boston Globe quotes MGH radiation oncologist Dr. Anthony Zietman - Trodelvy Improves Outcomes for Breast and Bladder Cancer
09/23/2020: Cancer Health coverage of presentation by MGH investigator Aditya Bardia - Dr. Bardia on the Results of the ASCENT Trial in Previously Treated Metastatic TNBC
09/21/2020: OncLive features MGH investigator Aditya Bardia - Sacituzumab govitecan improves survival in pretreated triple-negative breast cancer
09/19/2020: HemOnc Today coverage of presentation by MGH investigator Aditya Bardia - Neurotoxicity after CAR T-cell therapy has no effect on survival in lymphoma subset
09/17/2020: HemOnc Today perspective by MGH Cancer Center investigator Jorg Dietrich - Coffee May Slow Spread of Colon Cancer
09/17/2020 - HealthDay News quotes MGH investigator Andrew Chan - Expert Discusses the BOSTON Trial of Selinexor in Multiple Myeloma
09/11/2020: Targeted Oncology features MGH investigator Noopur Raje - Piotrowska Addresses Immunotherapy Treatment in NSCLC With Mutation
09/07/2020: Targeted Oncology features MGH physician Zofia Piotrowska - Mesothelioma Guide Podcast Details New Quality of Life Study
09/03/2020: Mesothelioma Guide interview with MGH psychologist Lara Traeger - Inside the Operating Room: An Academic Surgeon's Journey
09/01/2020: Latino Surgical Society features MGH Pancreas and Biliary Surgery Program director Carlos Fernandez-Del Castillo - Regular Aspirin Use May Increase Older People’s Risk of Dying from Cancer
08/18/2020: National Cancer Institute coverage of study led by MGH investigator Andrew Chan - Researchers develop tool to predict CAR T-cell therapy-associated neurotoxicity
08/18/2020: HemOnc Today coverage of study co-authored by MGH investigator Daniel Rubin - An Expert Discusses the Future of Multiple Myeloma Treatments
08/18/2020: Cure features MGH investigator Betsy O'Donnell - Homing in on Brain Mets’ Distinct Alterations Offers Hope for Precision Medicine Approach
08/17/2020: Targeted Oncology coverage of presentation by MGH investigator Priscilla Brastianos - Tailored Messaging Needed to Get Cancer Screening Back on Track
08/17/2020: MedPage Today quotes MGH investigator Erica Warner - Aspirin may accelerate cancer progression in older individuals
08/17/2020: HemOnc Today coverage of study led by MGH investigator Andrew Chan - Could Daily Low-Dose Aspirin Hasten Cancer in Seniors
08/12/2020: HealthDay News coverage of study led by MGH investigator Andrew Chan - Dr. O'Donnell Discusses Ongoing Research Efforts in Multiple Myeloma
08/11/2020: OncLive features MGH investigator Betsy O'Donnell - Precision Medicine: Key Updates for Treatment of NSCLC
08/10/2020: OncLive features MGH physician Rebecca Heist - Trouble With Daily Activities Tied to Worse Cancer Outcomes
08/07/2020: Physician's Briefing coverage of study led by MGH investigator Daniel Lage - Dr. Raje on Efficacy With Melflufen in Triple-Refractory Myeloma
08/06/2020: OncLive features MGH investigator Noopur Raje - Dr. Raje on Remaining Questions in Multiple Myeloma
08/05/2020: OncLive features MGH investigator Noopur Raje - Dr. Raje on the Effectiveness of Quadruplet Therapies in Multiple Myeloma
07/29/2020: OncLive interview with MGH physician Noopur S. Raje - Examining ADAURA and the Advantages of Adjuvant Osimertinib in EGFR+ NSCLC
07/23/2020: OncLive features MGH Center for Innovation in Early Cancer Detection director Lecia Sequist - Ethnic minorities, patients with cancer at higher risk for COVID-19, app-based study shows
07/23/2020: HemOnc Today coverage of presentation by MGH investigator David Drew - Raje Relays Recent Developments in Multiple Myeloma
07/21/2020: OncLive quotes MGH investigator Noopur Raje - Big Data and Collaboration Seek to Fight Covid-19
07/21/2020: The Scientist quotes MGH investigator Andrew Chan - Multiple Myeloma: Planning a Continuum of Care in 2020
07/17/2020: OncLive features MGH investigator Noopur Raje - Dr. Raje on the Design of the ENDURANCE Trial in Newly Diagnosed Multiple Myeloma
07/14/2020: OncLive features MGH investigator Noopur Raje - Functional Status May Predict Outcomes in Hospitalized Patients With Advanced Cancer
06/30/2020: Oncology Nurse Advisor coverage of study led by MGH investigator Daniel Lage - Dr. Raje on the Rationale for CAR T-Cell Therapy in Multiple Myeloma
06/29/2020: OncLive features MGH investigator Noopur Raje - As He Cut My Hair, I Wept
06/26/2020: New York Times mentions patient care at MGH - New Guideline Issued for Managing Advanced Prostate Cancer
06/25/2020: Renal & Urology News quotes MGH physician Keyan Salari - Clinical Challenges: HR+/HER2- Advanced Breast Cancer and CDK4/6 Inhibitors
06/25/20: MedPage Today quotes MGH investigator Aditya Bardia - Breakthroughs in HCC and Liver Cancer From ASCO 2020
06/25/2020: Medscape features MGH investigator Andrew Zhu - Many patients develop clinically significant PTSD symptoms early after HSCT
06/24/2020: HemOnc Today quotes MGH investigator Areej El-Jawahri - New Diagnostic Algorithms Have Prognostic Implications in Endometrial Cancer
06/24/2020: OncLive coverage of presentation by MGH investigator Lauren Ritterhouse - Fearing The Deadly Combo Of COVID-19 And Cancer
06/24/2020: Kaiser Health News mentions patient treatment at the MGH Termeer Center for Targeted Therapies - New Immunotherapy Combinations Look to Create Maximum Velocity in Immune Systems Response to Cancer
06/23/2020: Cure quotes MGH investigator G. Dan Duda - Advances in the Treatment of Malignant Melanoma
6/23/2020: OncLive features MGH physician Ryan Sullivan - Clinical Challenges in Colorectal Cancer: Integration of Immunotherapy
06/22/2020: MedPage Today quotes MGH investigator Ryan Nipp - Updates in the Management of Graft-Versus-Host Disease
06/19/2020: OncLive video features MGH physician Zachariah DeFilipp - Clinical Challenges: ADCs and Triple-Negative Breast Cancer
06/18/2020: MedPage Today quotes MGH investigator Aditya Bardia - Lenvatinib, Pembrolizumab Combination Promising in Unresectable HCC
06/12/2020: Cancer Therapy Advisor coverage of presentation by MGH investigator Andrew Zhu - Many Hospitalized Patients With Advanced Cancer Struggle With Daily Tasks, Worse Survival Rates
06/10/2020: Pharmacy Times coverage of study led by MGH investigator Daniel Lage - Study Identifies Independent Predictors of Smoldering Multiple Myeloma Progression
06/09/2020: Targeted Oncology coverage of study co-led by MGH investigator Gad Getz - Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future
06/03/2020: STAT News quotes MGH investigator Marcela Maus - Additional blood cancer responses seen with Allogene’s off-the-shelf CAR-T cells, updated study shows
05/29/2020: STAT News quotes MGH investigator Marcela Maus - Aspirin doubles risk for upper GI bleeding events in older adults
05/28/2020: Healio Gastroenterology coverage of study led by MGH investigator Andrew Chan - Long-term pancreatic cancer survivor shares his journey of hope
05/24/2020: MassLive mentions treatment by MGH physicians Andrew Warshaw and David Ryan - How to launch a drug in a pandemic with Immunomedics
05/18/2020: Pharmaceutical Technology quotes MGH investigator Aditya Bardia - Weekly Webinar Series Part 7: Managing Lung Cancer Patients Through the COVID-19 Pandemic: What to Know
05/18/2020: OncLive features MGH investigator Anna Farago - Dr. Branagan on the Results of the TOURMALINE-MM3 Trial in Multiple Myeloma
05/14/2020: OncLive video features MGH investigator Andrew Branagan - FDA Approves RET Inhibitor Retevmo for Lung and Thyroid Cancer
05/13/2020: Cancer Health quotes MGH physician Lori Wirth - App Shows Promise in Tracking New Coronavirus Cases, Study Finds
05/11/2020: New York Times coverage of study led by MGH investigator Andrew Chan - A cancer patient reconsiders her end-of-life wishes, as Covid-19 brings mortality into sharper focus
05/05/2020: STAT News mentions patient care at MGH, quotes physicians Juliet Jacobsen and Laura Petrillo - Community holds parade for Grafton man facing terminal cancer diagnosis
05/03/2020: WCVB mentions patient treatment at MGH - Rome Therapeutics launches to probe junk DNA for cancer drug discovery
04/27/2020: Chemical & Engineering News mentions research by MGH investigator David Ting - Cancer patient forgoing chemo during COVID-19 pandemic
04/24/2020: Boston 25 News report features MGH physician Steven Isakoff - Close-Up Views of Tumors Reveal a New Cancer Biology
04/21/2020: Scientific American quotes MGH investigators Bradley Bernstein and Mario Suvà - MGH doctors, both COVID-19 positive, talk about struggle to recover
04/14/2020: Fox 25 video report features MGH investigator Noopur Raje and physician Jag Singh - They're Doctors. They're Married. They Both Have Coronavirus. But Only 1 Got Critically Ill
04/10/2020: WBUR/CommonHealth interview with MGH investigator Noopur Raje and physician Jag Singh - US trial of Japanese flu drug for coronavirus gets green light
04/07/2020: New York Post quotes investigator Keith Flaherty - Massachusetts to launch first US trial of Japanese coronavirus drug
04/07/2020: Boston Globe coverage of MGH trial quoting investigator Keith Flaherty - Runners on the Frontlines: “This Situation is Like a Marathon I Have Been Training For My Entire Life”
04/06/2020: Women's Running quotes MGH physician Amy Comander - Coronavirus Fight: Download A Symptom Tracker App To Help Researchers
04/06/2020: CBS Boston video report features MGH investigator Andrew Chan - Cancer care in the age of COVID-19
04/06/2020: North Carolina Health News quotes MGH physician Zosia Piotrowska - Help Researchers Track the Coronavirus Spread With This App
04/02/2020: Lifehacker coverage of app co-developed by MGH investigator Andrew Chan - I'm A Doctor Who Got COVID-19. Here's What I Learned
04/01/2020: WBUR/CommonHealth perspective by MGH physician Aparna Raj Parikh - How Are You Feeling? Surveys Aim to Detect Covid-19 Hot Spots Early
04/01/2020: New York Times coverage of app co-developed by MGH investigator Andrew Chan - Worried about contracting COVID-19? Local health experts have an app for that
03/30/2020: WHDH coverage of app co-developed by MGH investigator Andrew Chan - App that tracks coronavirus symptoms has Massachusetts ties
03/30/2020: WCVB coverage of app co-developed by MGH investigator Andrew Chan - Race, Insurance Status Linked to Lower Cancer Survival
03/17/2020: Physician's Briefing coverage of study led by MGH investigator Luke Pike - 'MultiD': Taking the Bias Out of Prostate Cancer Tx
03/13/2020: MedPage Today mentions 2012 study led by MGH investigator Jason Efstathiou - Kevin Hughes, MD, on Breast Cancer Treatment Moving Forward
03/12/2020: Cancer Network video features MGH physician - Navigating Treatment Options for Patients With Early-Stage Breast Cancer
03/11/2020: OncLive coverage of study led by MGH investigator Aditya Bardia - Dr. Hughes on Genetic Testing in Breast Cancer
03/09/2020: OncLive video features MGH physician Kevin Hughes - Neoadjuvant Endocrine Therapy Less Toxic Than Chemo in Advanced, ER-Positive Breast Cancer
03/04/2020: Oncology Learning Network interview with MGH physician Aditya Bardia - Sexual Health and Cancer: What All Women Need to Know (and Usually Aren’t Told) After a Cancer Diagnosis
03/02/2020: Bay State Banner preview of event co-sponsored by MGH CARE program, Coils to Locs program - More Work Needed to Determine Best Treatment for High-Risk Myeloma
03/02/2020: Oncology Nursing News interview with MGH physician Andrew Branagan - Dr. Piotrowska on Eligibility Criteria for Osimertinib in Lung Cancer Treatment
03/02/2020: OncLive video features MGH investigator, Dr. Piotrowska - Existing CAR T Cells Show Promise Even as Newer Agents Emerge in Multiple Myeloma
03/02/2020: Targeted Oncology interview with MGH investigator Noopur Raje - Rethinking clinical trials for next-generation cancer drugs
02/27/2020: Knowable Magazine quotes MGH physician Keith Flaherty - Annual breast cancer screening in women older than 75 years may not reduce mortality
02/26/2020: Healio coverage of study led by MGH investigator Xabier García-Albéniz - Mammography in Women Older Than 75 Does Not Confer an Additional Survival Benefit
02/26/2020: AJMC.com coverage of study co-led by MGH investigators Katrina Armstrong, Mary Price and John Hsu - HPV-Positive Oropharyngeal Cancer Outcomes Differ by Race and Insurance Status
02/14/2020: Dentistry Today coverage of study led by MGH investigator Luke R.G. Pike - Data Mining Techniques Could Improve Cancer Gene Therapies
02/11/2020: Health IT Analytics coverage of study co-led by MGH investigator Jordi Merino - Bell Ringing Not So Joyous for Cancer Patients?
02/11/2020: MedPage Today quotes podcast featuring MGH physician Anthony Zietman - A team of scientists examined more than 2,600 cancer genomes. Here's what they found.
02/10/2020: Advisory Board features coverage of study co-led by MGH investigator Gad Getz - Testing for RET Fusions in NSCLC Remains Critical as Targeted Therapy BLU-667 Evolves
02/10/2020: Targeted Oncology coverage of study led by MGH investigator Justin Gainor - Should EGFR TKI Use Expand in Frontline NSCLC?
02/10/2020: OncLive coverage of presentation by MGH investigator Zosia Piotrowska - Potential New Metabolic Biomarkers of Lung Cancer Identified with Magnetic Resonance Spectroscopy
02/10/2020: News Medical.net coverage of MGH study - Foundation presents grants to six early career cancer researchers
02/09/2020: Healio announces MGH investigator Mario Suvà as grant recipient - Hematology scholars to participate in ASH faculty development program
02/01/2020: Healio announces MGH physician Gabriela Hobbs as faculty development program participant - Dr. Gainor on Neoadjuvant Use of Biomarkers in Nonmetastatic Lung Cancer
01/30/2020: OncLive video features MGH physician Justin Gainor - Talking Tumors: Contemplating Clinical Conundrums in Lung Cancer
01/30/2020: OncLive podcast features MGH physicians Lecia Sequist and Zofia Piotrowska - Danielle S. Bitterman, MD, on Pancreatic Cancer: Noninvasive Genomic Profiling From Plasma ctDNA
01/29/2020: ASCO Post video features MGH physician - If you face a life-or-death medical crisis, can you trust artificial intelligence (AI) to make the best decision?
01/28/2020: Genetic Literacy Project coverage of study led by MGH investigator Constance Lehman - Photos: Mass General Cancer Center’s CenterStage Gala
01/24/2020: Boston Magazine coverage of event benefiting MGH Cancer Center - 'Surprising' Number of Cancer Survivors Use Alcohol
01/23/2020: MedPage Today quotes MGH physician Jeffrey Peppercorn - ‘How long do I have?’ A website on cancer survival rates, from the co-founder of GoodRx, seeks to provide clarity
01/15/2020: STAT News includes quotes from MGH physician Jennifer Temel - AI spots cancer better than radiologists
01/15/2020: Technowize Magazine quotes MGH physician Constance Lehman - Breast cancer prediction: How Artificial Intelligence can save lives?
01/14/2020: TechGenyz quotes MGH researcher Constance Lehman - Chinese herbal may be chemoprotective against colorectal cancer
01/14/2020: MedPage Today includes commentary from MGH physicians Sohee Kwon and Andrew Chan - What Does Google’s Breast Cancer Screening A.I. Actually Do?
01/09/2020: Smithsonian Magazine quotes MGH physician Constance Lehman from previous article - How to Talk to Your Kids About Your Breast Cancer Diagnosis
01/07/2020: Parents quotes MGH physician Paula Rauch - Checkpoint Inhibitors Advance Standard of Care for Non-Small Cell Lung Cancer
01/07/2020: Targeted Oncology video features MGH investigator Justin Gainor - Study raises questions about hair dye and breast cancer
01/03/2020: Seacoast Online quotes MGH/Exeter physician YongLi Ji - A.I. Is Learning to Read Mammograms
01/02/2020: New York Times quotes MGH investigator Constance Lehman
The Story Project
The Story Project is our effort to capture the stories from the people in our Mass General Cancer Center community.
>4,500 People
participated in Clinical Trials at the Mass General Cancer Center last year
This helped lead to new knowledge and breakthrough therapies.
Support the Mass General Cancer Center
Your gift will open new doors in outstanding patient care, research, clinical education and community outreach.
Contact the Mass General Cancer Center
Contact us to make an appointment or to learn more about our programs.